The Effects of Focal Muscle Vibration Combined With Exercise on Sensorimotor Activity in Individuals With Chronic Subacromial Impingement Syndrome

NCT ID: NCT06694402

Last Updated: 2025-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-08

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Subacromial impingement syndrome (SIS) is a common shoulder disorder characterized by pain, altered movement patterns, and functional impairment. Forty-four to sixty-five percents of the patients with SIS would develop chronic symptoms. Chronic subacromial impingement syndrome (CSIS) is involved in the alteration of central nervous system, such as somatosensory dysfunction and corticomotor changes. The treatments for these patients usually focus on shoulder control and strengthening exercise but no treatment has been found to be targeted on the alterations in somatosensory dysfunction. Focal muscle vibration (FMV) is a useful tool to provide proprioceptive stimulation and has showed short-term effects of improving sensorimotor performance in both healthy and diseased individuals when combined with exercise. To our knowledge, no study has used FMV combined with shoulder exercise for individuals with shoulder problems.

Purpose: To investigate the effects of FMV combined with exercise on somatosensory activity, corticomotor excitability, pain and function in individuals with CSIS.

Methods: This is a randomized control trial. We will recruit ninety subjects with CSIS to receive a 12-session treatment protocol of FMV combined with shoulder exercises. The subjects will be randomized into a treatment group or control group. While the treatment group will receive 20-minute FMV when doing strength training, the control group will have the vibrators attached on but without being turned on during strength training. Both groups will have a 10-20 minutes of shoulder control training following the FMV protocol. The outcomes will be measured before and after the 12-session treatment protocol and include measures of somatosensory activity (using Electroencephalography, EEG), corticomotor excitability (using transcranial magnetic stimulation, TMS), pressure pain threshold, depression scale, pain intensity in a numerical rating scale, and shoulder function. The somatosensory measures include somatosensory-evoked potentials and event-related potentials during arm elevation. Corticomotor measures include motor evoked potentials, active and rest motor threshold and cortical silent period as well as intracortical inhibitory and facilitatory mechanisms. Shoulder function will be measured with the disabilities of the arm, shoulder and hand scale, the patient-specific functional scale, and the global rating of change scale.

Statistical analysis: The continuous and categorical variables of basic data will be analyzed by and independent t test and a Chi-square test, respectively. A two-way mixed ANOVA will be used to test between-group and within-group intervention effects. If there is a significant interaction effect, post hoc pairwise comparisons with Bonferroni correction will be used. The alpha level is set at 0.05.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Focal Vibration Electroencephalography Transcranial Magnetic Stimulation Somatosensory Dysfunction Corticomotor Excitability Intracortical Inhibition Chronic Subacromial Impingement Syndrome Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

focal muscle vibration combined with exercise

Group Type EXPERIMENTAL

focal muscle vibration combined with exercise

Intervention Type DEVICE

The treatment group will receive a 30-minute intervention in each session. Focal muscle vibration will be applied to the anterior and lateral parts of shoulder to give a sensory stimulation while participants are doing eaercise.

exercise alone

Group Type ACTIVE_COMPARATOR

exercise

Intervention Type OTHER

The control group will receive 30-minute exercise without focal muslce vibration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

focal muscle vibration combined with exercise

The treatment group will receive a 30-minute intervention in each session. Focal muscle vibration will be applied to the anterior and lateral parts of shoulder to give a sensory stimulation while participants are doing eaercise.

Intervention Type DEVICE

exercise

The control group will receive 30-minute exercise without focal muslce vibration.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Anterior or lateral shoulder pain ≥ 3 months
2. 18 to 65 years old
3. The most pain intensity ≥ 3/10 Pain-Numeric Scale (NRS)
4. SIS, at least 3 positive findings of the following tests:

(1) Neer's test (2) Hawkins-Kennedy test (3) Empty can test (4) Resisted external rotation test (5) Presenting painful arc during arm elevation (6) Tenderness of the rotator cuff tendons

Exclusion Criteria

1. History of dislocation, fracture, adhesive capsulitis or surgery of upper extremity
2. Neck pain
3. Shoulder flexion or abduction less than 150 degrees
4. History of direct contact injury to the neck or upper extremities within the past 12 months
5. Brain injury and neurological impairment
6. Inflammatory cause of the pain (e.g., rheumatoid arthritis)
7. Psychosis and symptom of headache or dizziness
8. Taking centrally acting medication
9. Contraindications to the use of transcranial magnetic stimulation (TMS)
10. Received shoulder-related physical therapy or corticosteroid injections in the past three months.
11. Received high-concentration platelet-rich plasma (PRP) injections in the shoulder joint in the past year.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Yang Ming Chiao Tung University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yin-Liang Lin

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yin-Liang Lin, PhD

Role: PRINCIPAL_INVESTIGATOR

National Yang Ming Chaio Tung University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Yang Ming Chiao Tung University

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yin-Liang Lin, PhD

Role: CONTACT

+886-2-2826-7288

Szu-Yu Chiu, BS

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yin-Liang Lin, PhD

Role: primary

+886-2-28267288

Szu-Yu Chiu, BS

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NYCU113082AF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.